Gene · 406902
Papers3,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modulating glioblastoma chemotherapy response: Evaluating long non-coding RNA effects on DNA damage response, glioma stem cell function, and hypoxic processes. | Neurooncol Adv | 2022 | 36105389 | PubTator, text mining | PubMed |
| Comprehensive exploration of tumor immune microenvironment feature and therapeutic response in colorectal cancer based on a novel immune-related long non-coding RNA prognostic signature. | Front Genet | 2022 | 36092924 | PubTator, text mining | PubMed |
| Comprehensive analysis of GINS subunits prognostic value and ceRNA network in sarcoma. | Front Cell Dev Biol | 2022 | 36092720 | PubTator, text mining | PubMed |
| Research progress of exosomes in orthopedics. | Front Genet | 2022 | 36081990 | PubTator, text mining | PubMed |
| Multifunctional exosomes derived from bone marrow stem cells for fulfilled osseointegration. | Front Chem | 2022 | 36072705 | PubTator, text mining | PubMed |
| Clinical applications of liquid biopsy in HPV-negative and HPV-positive head and neck squamous cell carcinoma: advances and challenges. | Explor Target Antitumor Ther | 2022 | 36071985 | PubTator, text mining | PubMed |
| TENT2, TUT4, and TUT7 selectively regulate miRNA sequence and abundance. | Nat Commun | 2022 | 36071058 | PubTator, text mining | PubMed |
| Circulating microRNA associated with future relapse status in major depressive disorder. | Front Psychiatry | 2022 | 36061300 | PubTator, text mining | PubMed |
| miR-100-5p Promotes Epidermal Stem Cell Proliferation through Targeting MTMR3 to Activate PIP3/AKT and ERK Signaling Pathways. | Stem Cells Int | 2022 | 36045954 | PubTator, text mining | PubMed |
| Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma. | J Clin Lab Anal | 2022 | 36036748 | PubTator, text mining | PubMed |
| Non-coding RNAs in skin cancers:Biological roles and molecular mechanisms. | Front Pharmacol | 2022 | 36034860 | PubTator, text mining | PubMed |
| Small but strong: Pivotal roles and potential applications of snoRNAs in hematopoietic malignancies. | Front Oncol | 2022 | 36033520 | PubTator, text mining | PubMed |
| Opportunities and challenges for synthetic biology in the therapy of inflammatory bowel disease. | Front Bioeng Biotechnol | 2022 | 36032720 | PubTator, text mining | PubMed |
| Roles of microRNAs in Hepatitis C Virus Replication and Pathogenesis. | Viruses | 2022 | 36016398 | PubTator, text mining | PubMed |
| Potential Role of miR-196a and miR-196b as Prognostic Biomarkers of Survival in Head and Neck Squamous Cell Carcinoma: A Systematic Review, Meta-Analysis and Trial Sequential Analysis. | Life (Basel) | 2022 | 36013448 | PubTator, text mining | PubMed |
| Expression of MicroRNAs in Sepsis-Related Organ Dysfunction: A Systematic Review. | Int J Mol Sci | 2022 | 36012630 | PubTator, text mining | PubMed |
| Using ncRNAs as Tools in Cancer Diagnosis and Treatment-The Way towards Personalized Medicine to Improve Patients' Health. | Int J Mol Sci | 2022 | 36012617 | PubTator, text mining | PubMed |
| Quantitative Prediction of Steatosis in Patients with Non-Alcoholic Fatty Liver by Means of Hepatic MicroRNAs Present in Serum and Correlating with Hepatic Fat. | Int J Mol Sci | 2022 | 36012565 | PubTator, text mining | PubMed |
| The Immunomodulatory Role of Hypoxic Tumor-Derived Extracellular Vesicles. | Cancers (Basel) | 2022 | 36010994 | PubTator, text mining | PubMed |
| MicroRNAs and the Diagnosis of Childhood Acute Lymphoblastic Leukemia: Systematic Review, Meta-Analysis and Re-Analysis with Novel Small RNA-Seq Tools. | Cancers (Basel) | 2022 | 36010971 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406902/papers?page=28